Bristol-Myers Squibb to close Irish plant


Bristol-Myers Squibb (BMS) is to close its manufacturing plant in Cruiserath, Ireland, with the loss of 130 jobs by the end of 2015. A further 30 positions will be cut at the nearby plant in Swords as one of several operating units on that site is also shuttered.

BMS tied the closures to ‘changing market demand’ for its products, along with efforts to optimise its manufacturing network. The remaining 320 employees at the Swords plant will continue to manufacture bulk pharmaceuticals.

Susan Hynes, BMS’s general manager of active pharmaceutical ingredient operations Ireland, said in a statement that ‘the company is working to explore potential future uses of the Cruiserath facility and will endeavour to minimise job losses in Ireland’.


Related Content

GSK’s ViiV to buy HIV drugs from BMS

11 January 2016 Business

news image

Deal hands over Bristol-Myers Squibb’s entire HIV pipeline as the company looks to quit virology research

Bristol-Myers Squibb fined for alleged Chinese bribes

7 October 2015 Business

news image

US Securities and Exchange Commission accepts $14m settlement for charges covering the last five years

Most Commented

Ethanol to butanol conversion shows sustainable potential

13 January 2016 Research

news image

Borrowed hydrogen chemistry drives reaction to obtain useful fuel from biomass

Injectable foam repairs bones

22 December 2015 Research

news image

Scientists say biomaterial could treat bone defects and diseases